Decision Support

It has recently received $22 million in foreign direct investment to launch a national AI program.

Clinical decision support technology has enabled automatic inclusion of risk results in the health system's reports. Among many other improvements, the ability to stratify patients earlier and more accurately allows staff to provide additional care before cancer is detected.

Julia Zarb, CEO and founder of Blue x Blue and a 2025 HIMSS Changemaker Award recipient, says her company uses AI agents to identify and access the data most needed to make informed choices, helping drive efficiency and relieve burnout.